Christy J. Oliger is of Nuvalent, Inc.. Currently has a direct ownership of 3,971 shares of NUVL, which is worth approximately $297,825. The most recent transaction as insider was on Jun 18, 2025, when has been sold 3,971 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.97K
n/a 3M change
n/a 12M change
Total Value Held $297,825

Christy J. Oliger Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 18 2025
BUY
Grant, award, or other acquisition
-
3,971 Added 50.0%
3,971 Class A Common Stock

Also insider at

RETA
REATA PHARMACEUTICALS INC Healthcare
RYZB
RayzeBio, Inc.
KPTI
Karyopharm Therapeutics Inc. Healthcare
SRRA
Sierra Oncology, Inc. Healthcare
REPL
Replimune Group, Inc. Healthcare
VERA
Vera Therapeutics, Inc. Healthcare
LVTX
LAVA Therapeutics NV Healthcare
CJO

Christy J. Oliger

Plano, TX

Track Institutional and Insider Activities on NUVL

Follow Nuvalent, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NUVL shares.

Notify only if

Insider Trading

Get notified when an Nuvalent, Inc. insider buys or sells NUVL shares.

Notify only if

News

Receive news related to Nuvalent, Inc.

Track Activities on NUVL